MA29015B1 - Agents de liaison specifiques de l'angiopoietine-2 - Google Patents
Agents de liaison specifiques de l'angiopoietine-2Info
- Publication number
- MA29015B1 MA29015B1 MA29892A MA29892A MA29015B1 MA 29015 B1 MA29015 B1 MA 29015B1 MA 29892 A MA29892 A MA 29892A MA 29892 A MA29892 A MA 29892A MA 29015 B1 MA29015 B1 MA 29015B1
- Authority
- MA
- Morocco
- Prior art keywords
- angiopoietin
- specific binding
- binding agents
- agents
- specific
- Prior art date
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62016104P | 2004-10-19 | 2004-10-19 | |
US10/982,440 US7658924B2 (en) | 2001-10-11 | 2004-11-04 | Angiopoietin-2 specific binding agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29015B1 true MA29015B1 (fr) | 2007-11-01 |
Family
ID=39608222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29892A MA29015B1 (fr) | 2004-10-19 | 2007-05-11 | Agents de liaison specifiques de l'angiopoietine-2 |
Country Status (10)
Country | Link |
---|---|
JP (2) | JP2008520188A (fr) |
CN (1) | CN101495513B (fr) |
BR (1) | BRPI0518209A (fr) |
EA (1) | EA011866B1 (fr) |
IL (1) | IL182279A0 (fr) |
MA (1) | MA29015B1 (fr) |
MX (1) | MX2007004247A (fr) |
RU (2) | RU2404992C2 (fr) |
SG (1) | SG156668A1 (fr) |
ZA (1) | ZA200704020B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA011866B1 (ru) * | 2004-10-19 | 2009-06-30 | Амджен Инк. | Агенты, специфически связывающие ангиопоэтин-2 |
JO3182B1 (ar) * | 2009-07-29 | 2018-03-08 | Regeneron Pharma | مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2 |
EA022546B1 (ru) * | 2011-09-28 | 2016-01-29 | Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук | Способ торможения роста карциномы эрлиха у лабораторного животного |
SI2760471T1 (sl) * | 2011-09-30 | 2017-04-26 | Dana-Farber Cancer Institute, Inc. | Terapevtski peptidi |
MX357393B (es) * | 2012-01-23 | 2018-07-06 | Regeneron Pharma | Formulaciones estabilizadas que contienen anticuerpos anti - ang2. |
WO2014100834A1 (fr) * | 2012-12-21 | 2014-06-26 | The Regents Of The University Of California | Méthodes et compositions pour le traitement de la toxicité du cyanure et de sulfure d'hydrogène |
ES2687968T3 (es) * | 2013-05-14 | 2018-10-30 | Eisai R&D Management Co., Ltd. | Biomarcadores para pronosticar y evaluar la reactividad de sujetos con cáncer de endometrio a compuestos con lenvatinib |
AR100270A1 (es) * | 2014-05-19 | 2016-09-21 | Lilly Co Eli | Anticuerpos ang2 |
BR112017002827B1 (pt) | 2014-08-28 | 2023-04-18 | Eisai R&D Management Co., Ltd | Derivado de quinolina altamente puro e método para produção do mesmo |
MX2017010474A (es) | 2015-02-25 | 2017-11-28 | Eisai R&D Man Co Ltd | Metodo para suprimir el amargor de un derivado de quinoleina. |
KR20240064733A (ko) | 2015-03-04 | 2024-05-13 | 머크 샤프 앤드 돔 코포레이션 | 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합 |
SG11201710198YA (en) | 2015-06-16 | 2018-01-30 | Eisai R&D Man Co Ltd | Anticancer agent |
CN106512006A (zh) * | 2016-07-25 | 2017-03-22 | 广州道瑞医药科技有限公司 | Angpt2分泌抑制剂在制备用于治疗血管瘤的药物中的应用 |
CN106075448A (zh) * | 2016-07-25 | 2016-11-09 | 广州道瑞医药科技有限公司 | Angpt2抑制剂在制备用于治疗血管瘤的药物中的应用 |
CN109096368B (zh) * | 2018-09-30 | 2021-07-20 | 华南理工大学 | 一种同时具有抗氧化和护肝活性的多肽及编码该多肽的基因与其制备方法和应用 |
KR102527315B1 (ko) * | 2019-02-25 | 2023-05-03 | 주식회사 파멥신 | 항-Ang2 항체 및 이의 용도 |
CN112126671B (zh) * | 2020-08-18 | 2021-08-31 | 中山大学附属第五医院 | 无乳链球菌Streptococus agalactiae治疗子宫内膜异位症的应用 |
CN116265487A (zh) * | 2021-12-16 | 2023-06-20 | 三优生物医药(上海)有限公司 | 抗ang2-vegf双特异性抗体及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ514434A (en) * | 1999-03-26 | 2003-11-28 | Univ California | Modulation of vascular permeability by means of TIE2 receptor activators |
US7205275B2 (en) * | 2001-10-11 | 2007-04-17 | Amgen Inc. | Methods of treatment using specific binding agents of human angiopoietin-2 |
US7521053B2 (en) * | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
WO2003030883A1 (fr) * | 2001-10-12 | 2003-04-17 | Kosmos Pharma | Couches minces uniformes servant a dissoudre rapidement une forme galenique incorporant des compositions de masquage de gout |
EA011866B1 (ru) * | 2004-10-19 | 2009-06-30 | Амджен Инк. | Агенты, специфически связывающие ангиопоэтин-2 |
-
2005
- 2005-10-19 EA EA200700876A patent/EA011866B1/ru not_active IP Right Cessation
- 2005-10-19 BR BRPI0518209-3A patent/BRPI0518209A/pt not_active IP Right Cessation
- 2005-10-19 RU RU2007118670/13A patent/RU2404992C2/ru not_active IP Right Cessation
- 2005-10-19 MX MX2007004247A patent/MX2007004247A/es active IP Right Grant
- 2005-10-19 SG SG200907008-7A patent/SG156668A1/en unknown
- 2005-10-19 CN CN200580043569.5A patent/CN101495513B/zh not_active Expired - Fee Related
- 2005-10-19 JP JP2007538066A patent/JP2008520188A/ja active Pending
-
2007
- 2007-03-28 IL IL182279A patent/IL182279A0/en unknown
- 2007-05-11 MA MA29892A patent/MA29015B1/fr unknown
- 2007-05-18 ZA ZA200704020A patent/ZA200704020B/en unknown
-
2010
- 2010-08-05 RU RU2010132956/10A patent/RU2010132956A/ru not_active Application Discontinuation
-
2011
- 2011-03-30 JP JP2011075243A patent/JP2011207882A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
RU2404992C2 (ru) | 2010-11-27 |
BRPI0518209A (pt) | 2008-11-04 |
IL182279A0 (en) | 2007-07-24 |
JP2011207882A (ja) | 2011-10-20 |
RU2007118670A (ru) | 2008-12-27 |
ZA200704020B (en) | 2008-06-25 |
CN101495513B (zh) | 2014-08-06 |
RU2010132956A (ru) | 2012-02-10 |
JP2008520188A (ja) | 2008-06-19 |
EA011866B1 (ru) | 2009-06-30 |
SG156668A1 (en) | 2009-11-26 |
CN101495513A (zh) | 2009-07-29 |
MX2007004247A (es) | 2007-06-12 |
EA200700876A1 (ru) | 2007-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29015B1 (fr) | Agents de liaison specifiques de l'angiopoietine-2 | |
NO20041907L (no) | Angiopoietin-2 spesifikke bindinsmidler | |
DE602004019159D1 (de) | Drosselklappenstutzen | |
FR2871145B1 (fr) | Distributeur d'applicateurs | |
GB0307671D0 (en) | Improvements relating to the construction of playing surfaces | |
DE60134988D1 (de) | Verknüpfbare elastomerzusammensetzung | |
FR2875398B1 (fr) | Implant articulaire d'interposition | |
MA28812B1 (fr) | Combinaisons d'epothilone | |
FR2880793B1 (fr) | Prothese d'epaule | |
FR2879635B1 (fr) | Connecteur d'ossature | |
DE602004017295D1 (de) | Drosselkörper | |
IL190045A0 (en) | Use of c3-c10 17 alfa-esters of 9,11-dehydrocortexolone as anti-gonadotrophic agents | |
DK1960510T3 (da) | Ammoniakspecifik 5'-xmp-aminasemutant | |
FR2879109B1 (fr) | Composition absorbante d'humidite | |
FR2853380B1 (fr) | Articulation elastique | |
GB0403791D0 (en) | 'Kwicap' | |
FR2878004B3 (fr) | Ferrure d'angle | |
FR2852042B1 (fr) | Piece d'aretier | |
ITSV20040008A1 (it) | Dottor "g" | |
ITMN20040010A1 (it) | Portamenu' | |
UA9704S (uk) | Сані дитячі | |
ES1054827Y (es) | "purificador de gasoil" | |
FR2862726B1 (fr) | Organe de liaison | |
GB0406046D0 (en) | Affinity purification of protein | |
GB0516729D0 (en) | BB's |